Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Liver Cirrhosis | 3 | 2021 | 1810 | 0.80 | Why? |
| Liver Transplantation | 3 | 2021 | 2864 | 0.62 | Why? |
| Nurse Practitioners | 1 | 2019 | 248 | 0.59 | Why? |
| Inflammatory Bowel Diseases | 3 | 2021 | 3209 | 0.59 | Why? |
| End Stage Liver Disease | 1 | 2019 | 418 | 0.54 | Why? |
| Veterans | 3 | 2021 | 1131 | 0.53 | Why? |
| Postoperative Care | 1 | 2019 | 755 | 0.51 | Why? |
| Carcinoma, Hepatocellular | 1 | 2021 | 1222 | 0.42 | Why? |
| Veterans Health | 2 | 2021 | 169 | 0.40 | Why? |
| Patient Readmission | 1 | 2019 | 1543 | 0.39 | Why? |
| Liver Neoplasms | 1 | 2021 | 1666 | 0.37 | Why? |
| Tissue and Organ Procurement | 1 | 2019 | 1277 | 0.36 | Why? |
| Liver Diseases | 1 | 2019 | 2698 | 0.26 | Why? |
| Surgical Procedures, Operative | 1 | 2019 | 2662 | 0.25 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.24 | Why? |
| Immunosuppressive Agents | 1 | 2021 | 6331 | 0.24 | Why? |
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2021 | 41 | 0.22 | Why? |
| Hepatitis, Alcoholic | 1 | 2021 | 61 | 0.22 | Why? |
| Waiting Lists | 2 | 2019 | 1388 | 0.21 | Why? |
| Transplantation Conditioning | 2 | 2018 | 323 | 0.19 | Why? |
| Hemoglobins, Abnormal | 1 | 2017 | 6 | 0.18 | Why? |
| Transplantation, Haploidentical | 1 | 2018 | 53 | 0.18 | Why? |
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2018 | 75 | 0.18 | Why? |
| Antigens, CD34 | 2 | 2017 | 125 | 0.18 | Why? |
| Polycythemia | 1 | 2017 | 19 | 0.18 | Why? |
| Peripheral Blood Stem Cell Transplantation | 1 | 2018 | 86 | 0.18 | Why? |
| Authorship | 1 | 2021 | 240 | 0.18 | Why? |
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 112 | 0.17 | Why? |
| Hemoglobinopathies | 1 | 2017 | 90 | 0.17 | Why? |
| CD3 Complex | 1 | 2017 | 237 | 0.16 | Why? |
| Genotyping Techniques | 1 | 2018 | 360 | 0.15 | Why? |
| Acute-On-Chronic Liver Failure | 1 | 2019 | 237 | 0.15 | Why? |
| Cohort Studies | 6 | 2021 | 36005 | 0.15 | Why? |
| United States | 8 | 2021 | 46150 | 0.15 | Why? |
| Abatacept | 1 | 2017 | 192 | 0.15 | Why? |
| Graft Survival | 1 | 2018 | 587 | 0.14 | Why? |
| Hospital Mortality | 1 | 2019 | 22087 | 0.14 | Why? |
| Bibliometrics | 1 | 2021 | 731 | 0.12 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.12 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.11 | Why? |
| Pancreatic Neoplasms | 1 | 2018 | 609 | 0.11 | Why? |
| Anemia, Sickle Cell | 1 | 2018 | 546 | 0.11 | Why? |
| Program Evaluation | 1 | 2019 | 1929 | 0.10 | Why? |
| Endoscopy, Gastrointestinal | 1 | 2021 | 1545 | 0.10 | Why? |
| Aged | 10 | 2021 | 215776 | 0.10 | Why? |
| Professional Role | 1 | 2019 | 1280 | 0.10 | Why? |
| Early Detection of Cancer | 1 | 2021 | 1956 | 0.09 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.09 | Why? |
| Multiple Myeloma | 1 | 2017 | 1064 | 0.09 | Why? |
| Periodicals as Topic | 1 | 2021 | 1492 | 0.09 | Why? |
| Female | 15 | 2021 | 380317 | 0.08 | Why? |
| Male | 14 | 2021 | 367725 | 0.08 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.08 | Why? |
| Pilot Projects | 1 | 2019 | 5182 | 0.08 | Why? |
| Graft Rejection | 1 | 2017 | 1766 | 0.08 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.08 | Why? |
| Humans | 19 | 2021 | 930598 | 0.08 | Why? |
| Cardiology | 1 | 2021 | 2873 | 0.07 | Why? |
| Sex Factors | 2 | 2021 | 11014 | 0.07 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.07 | Why? |
| Hematopoietic Stem Cell Transplantation | 2 | 2017 | 2426 | 0.07 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.06 | Why? |
| Practice Patterns, Physicians' | 1 | 2021 | 4927 | 0.06 | Why? |
| Mesoderm | 1 | 2001 | 15 | 0.06 | Why? |
| Papio | 1 | 2001 | 104 | 0.05 | Why? |
| Postoperative Complications | 1 | 2019 | 5861 | 0.05 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.05 | Why? |
| Registries | 1 | 2019 | 12327 | 0.05 | Why? |
| Pennsylvania | 1 | 2021 | 558 | 0.05 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.05 | Why? |
| Whole-Body Irradiation | 1 | 2017 | 42 | 0.04 | Why? |
| Maximum Tolerated Dose | 1 | 2017 | 65 | 0.04 | Why? |
| Melphalan | 1 | 2017 | 46 | 0.04 | Why? |
| Mice, Inbred NOD | 1 | 2017 | 134 | 0.04 | Why? |
| Bone Marrow | 1 | 2001 | 492 | 0.04 | Why? |
| Retreatment | 1 | 2017 | 186 | 0.04 | Why? |
| Heterografts | 1 | 2017 | 203 | 0.04 | Why? |
| United States Department of Veterans Affairs | 1 | 2021 | 553 | 0.04 | Why? |
| Homozygote | 1 | 2017 | 230 | 0.04 | Why? |
| Pedigree | 1 | 2017 | 502 | 0.04 | Why? |
| Transplantation, Autologous | 1 | 2017 | 364 | 0.04 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Stem Cell Transplantation | 1 | 2001 | 531 | 0.04 | Why? |
| Stem Cells | 1 | 2001 | 595 | 0.04 | Why? |
| Reoperation | 1 | 2017 | 544 | 0.03 | Why? |
| Drug Resistance, Neoplasm | 1 | 2017 | 447 | 0.03 | Why? |
| Propensity Score | 1 | 2021 | 2690 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
| Adult | 7 | 2021 | 244371 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.02 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| DNA, Recombinant | 1 | 2001 | 94 | 0.01 | Why? |
| Leukocyte Common Antigens | 1 | 2001 | 101 | 0.01 | Why? |
| Specimen Handling | 1 | 2018 | 6190 | 0.01 | Why? |
| Luminescent Proteins | 1 | 2001 | 142 | 0.01 | Why? |
| Hematopoiesis | 1 | 2001 | 168 | 0.01 | Why? |
| Transgenes | 1 | 2001 | 227 | 0.01 | Why? |
| Alkaline Phosphatase | 1 | 2001 | 257 | 0.01 | Why? |
| Green Fluorescent Proteins | 1 | 2001 | 450 | 0.01 | Why? |
| Cell Separation | 1 | 2001 | 270 | 0.01 | Why? |
| Transfection | 1 | 2001 | 864 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Pandemics | 2 | 2021 | 389249 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Animals | 2 | 2017 | 78931 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2019 | 48226 | 0.01 | Why? |
| Cells, Cultured | 1 | 2001 | 5835 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2001 | 6740 | 0.00 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 7868 | 0.00 | Why? |
| Antibodies, Monoclonal | 1 | 2001 | 8041 | 0.00 | Why? |
Mahmud's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(118)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(51)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_